Literature DB >> 9685391

Isolation, cloning, and sequence analysis of the integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes.

L Camper1, U Hellman, E Lundgren-Akerlund.   

Abstract

We have found that chondrocytes express a novel collagen type II-binding integrin, a new member of the beta1-integrin family. The integrin alpha subunit, which has a Mr of 160 kDa reduced, was isolated from bovine chondrocytes by collagen type II affinity purification. The human homologue was obtained by screening a human chondrocyte library with a bovine cDNA probe. Cloning and cDNA sequence analysis of the human integrin alpha subunit designated alpha10 show that it shares the general structure of other integrin alpha subunits. The predicted amino acid sequence consists of a 1167-amino acid mature protein, including a signal peptide (22 amino acids), a long extracellular domain (1098 amino acids), a transmembrane domain (25 amino acids), and a short cytoplasmic domain (22 amino acids). The extracellular part contains a 7-fold repeated sequence, an I-domain (199 amino acids) and three putative divalent cation-binding sites. The deduced amino acid sequence of alpha10 is 35% identical to the integrin subunit alpha2 and 37% identical to the integrin subunit alpha1. Northern blot analysis shows a single mRNA of 5.4 kilobases in chondrocytes. A peptide antibody against the predicted sequence of the cytoplasmic domain of alpha10 immunoprecipitated two proteins with masses of 125 and 160 kDa from chondrocyte lysates under reducing conditions. The peptide antibody specifically stained chondrocytes in tissue sections of human articular cartilage, showing that alpha10 beta1 is expressed in cartilage tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685391     DOI: 10.1074/jbc.273.32.20383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Integrin signaling in fibrosis and scleroderma.

Authors:  H A Gardner
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

2.  Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.

Authors:  B Leitinger; N Hogg
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

Review 3.  Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.

Authors:  B Eckes; D Kessler; M Aumailley; T Krieg
Journal:  Springer Semin Immunopathol       Date:  1999

4.  Partial characterization of cell-type X collagen interactions.

Authors:  Steven P Luckman; Elaine Rees; Alvin P L Kwan
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

5.  The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site.

Authors:  Johannes A Eble; Danny S Tuckwell
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

Review 6.  Lessons from the alpha2 integrin knockout mouse.

Authors:  Arthur M Mercurio
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 7.  Origin of cardiac fibroblasts and the role of periostin.

Authors:  Paige Snider; Kara N Standley; Jian Wang; Mohamad Azhar; Thomas Doetschman; Simon J Conway
Journal:  Circ Res       Date:  2009-11-06       Impact factor: 17.367

8.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

9.  Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis.

Authors:  Guido Veit; Daniela Zwolanek; Beate Eckes; Stephan Niland; Jarmo Käpylä; Manon C Zweers; Akemi Ishada-Yamamoto; Thomas Krieg; Jyrki Heino; Johannes A Eble; Manuel Koch
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

10.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.

Authors:  Tomoyo Okada; Ann Y Lee; Li-Xuan Qin; Narasimhan Agaram; Takahiro Mimae; Yawei Shen; Rachael O'Connor; Miguel A López-Lago; Amanda Craig; Martin L Miller; Phaedra Agius; Evan Molinelli; Nicholas D Socci; Aimee M Crago; Fumi Shima; Chris Sander; Samuel Singer
Journal:  Cancer Discov       Date:  2016-08-30       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.